Yahoo Web Search

Search results

1. Alnylam Pharmaceuticals, Inc.

   NasdaqGS: ALNY

   265.35

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +3.44 (+1.31%)

   As of Thu. Sep 12, 2024 12:36 PM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	260.42
     High	266.80
     Low	259.99

   • Mkt Cap	34.07B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	261.91
     52 Wk. Low	141.98
     52 Wk. High	287.55

   More about ALNY

   What analysts are saying

   Morningstar Published September 06 · Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within... Read more

   Top stories

   • ALNY
     +1.31%

   Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?

   Yahoo Finance · 4 days ago

   

   • ALNY
     +1.31%

   ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam

   Yahoo Finance · 2 weeks ago

   

   • ALNY
     +1.31%
   • REGN
     +1.49%
   • ALMS
     +5.95%
   • ZBIO

   Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch

   Yahoo Finance · 1 week ago

   

   Related stocks

   • BMRN
     BioMarin Pharmaceutical Inc.
     BMRN
     84.29
     -0.58%
   • IONS
     Ionis Pharmaceuticals, Inc.
     IONS
     41.89
     -1.50%
   • SRPT
     Sarepta Therapeutics, Inc.
     SRPT
     126.97
     -1.11%
   • AGIO
     Agios Pharmaceuticals, Inc.
     AGIO
     45.11
     +1.81%
   • INCY
     Incyte Corporation
     INCY
     62.90
     -0.36%

   More on Yahoo Finance

2. www.marketbeat.com › originals › alnylam-stock-soarsAlnylam Stock Soars 65%: Find Out What’s Behind the Gains

   www.marketbeat.com › originals › alnylam-stock-soars

   • Cached

   16 hours ago · Alnylam Pharmaceuticals released the final results of a study that has it on track for expanded use of a key product. Expanded use could lead revenue to double or triple within the next two years. Analysts are raising their price targets and leading this market to another. 5 stocks we like better than Alnylam Pharmaceuticals

   • Alnylam Pharmaceuticals (ALNY) Stock Forecast and Price ...

     ALNY's current price target is $279.14. Learn why top...

   • Alnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis

     Alnylam Pharmaceuticals, Inc., a biopharmaceutical company,...

3. finance.yahoo.com › news › alnylam-pharmaceuticalsAlnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds ...

   finance.yahoo.com › news › alnylam-pharmaceuticals

   • Cached

   4 days ago · Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Number of Hedge Fund Holders: 53. One of the Best Biotech Stocks to Invest In According to Hedge Funds, a biopharmaceutical company, Alnylam ...

4. www.marketbeat.com › stocks › NASDAQAlnylam Pharmaceuticals (ALNY) Stock Forecast and Price ...

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   3 days ago · ALNY's current price target is $279.14. Learn why top analysts are making this stock forecast for Alnylam Pharmaceuticals at MarketBeat.

   • 3.7/5
   • Phone: (844) 978-6257

   • Location: 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
   • Email: investors@alnylam.com

5. People also ask

   Who owns Alnylam Pharmaceuticals?

   • The ownership of Alnylam Pharmaceuticals' stock is held by a variety of institutional and retail investors. No single entity owns the majority share.

   Alnylam Pharmaceuticals (ALNY) Stock Forecast, Price & News

   www.marketbeat.com/stocks/nasdaq/alny/

   See all results for this question

   What does Alnylam Pharmaceuticals do?

   • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Return vs Industry: ALNY exceeded the US Biotechs industry which returned 13.3% over the past year.

   Alnylam Pharmaceuticals (NasdaqGS:ALNY) - Share price

   simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals

   See all results for this question

   How much did Alnylam Pharmaceuticals (ALNY) earn?

   • Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings per share of ($2.21) for the quarter, which was $0.49 more than the analysts' consensus estimates of ($1.72).

   Alnylam Pharmaceuticals (ALNY) Stock Forecast, Price & News

   www.marketbeat.com/stocks/nasdaq/alny/

   See all results for this question

   When is Alnylam Pharmaceuticals' next earnings announcement?

   • Alnylam Pharmaceuticals' next earnings announcement is scheduled for Thursday, November 2nd 2023. The company will be holding an earnings conference call on this day at 8:30 AM Eastern. For more information, view our ALNY earnings forecast.

   Alnylam Pharmaceuticals (ALNY) Stock Forecast, Price & News

   www.marketbeat.com/stocks/nasdaq/alny/

   See all results for this question

6. simplywall.st › alnylam-pharmaceuticalsAlnylam Pharmaceuticals (Nasdaq:ALNY) - Simply Wall St

   simplywall.st › alnylam-pharmaceuticals

   • Cached

   4 days ago · Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the ...

   • 52 Week High: US$285.00
   • Beta: 0.37

   • 52 Week Low: US$141.98
   • Current Share Price: US$272.64

7. www.marketbeat.com › stocks › NASDAQAlnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   1 day ago · Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.

   • 3.7/5
   • Email: investors@alnylam.com

   • Phone: (617) 551-8200
   • Employees: 2.1K

8. www.bloomberg.com › quote › ALNY:USALNY: Alnylam Pharmaceuticals Inc Stock Price Quote - NASDAQ ...

   www.bloomberg.com › quote › ALNY:US

   • Cached

   1 day ago · Stock analysis for Alnylam Pharmaceuticals Inc (ALNY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

9. pharmaphorum.com › news › alnylam-hails-vutrisiranAlnylam hails vutrisiran data, but investors seem sceptical

   pharmaphorum.com › news › alnylam-hails-vutrisiran

   • Cached

   2 days ago · Alnylam Pharma has been riding high since revealing top-line results from its HELIOS-B trial of vutrisiran in transthyretin-mediated amyloidosis (ATTR) – but a look at the full data seems to ...